Committed to developing treatments
for orphan diseases

Laurent Pharmaceuticals is an orphan drug company with a clinical development program in cystic fibrosis.  

laurent Lauren2 Laurent3

Cystic Fibrosis




Laurent Pharmaceuticals to present at the BIOCOM 2019, February 26th-28th 2019, La Jolla, CA, USA

Laurent Pharmaceuticals to participate at RESI NYC 2018, November 5th 2018, New York City, USA



Laurent Pharmaceuticals Welcomes New Investors and Announces Scientific Breakthrough with LAU-7b in Cystic Fibrosis

Read more  

Laurent Pharmaceuticals reaches agreement with US Cystic Fibrosis Foundation to increase Development Award to $US 5M

Read more